Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

AMSCAMERICAN SUPERCONDUCTOR CORP /DE/

Nasdaq · CIK 0000880807
Filer categoryLarge accelerated filer
Entity typeoperating
SIC3621 Motors & Generators
FY end0331
XBRL facts544

Identity from submissions API

NameAMERICAN SUPERCONDUCTOR CORP /DE/
CIK0000880807
TickersAMSC
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC3621 Motors & Generators
EIN042959321
LEI—
Fiscal year end0331
State of incorporationDE DE
Phone9788423000
Website—
Investor website—
Owner org04 Manufacturing
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
SIXTY FOUR JACKSON ROAD
DEVENS
MA
01434
MA
Mailing address
SIXTY FOUR JACKSON ROAD
DEVENS
MA
01434
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1328 filing rows loaded from submissions recent; extra archives: CIK0000880807-submissions-001.json (327 filings, 1996-07-29 to 2008-02-05).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-04 10-Q FORM 10-Q 0001437749-26-034936 000-19672 261522189 34 9225765 1 1
2026-11-04 8-K FORM 8-K 2.02,9.01 0001437749-26-034935 000-19672 261522138 34 532899 1 1
2026-09-21 4 4 0001193125-26-396831 5105
2026-09-21 8-K FORM 8-K 5.02 0001437749-26-030822 000-19672 261394020 34 156942 1 1
2026-08-05 10-Q FORM 10-Q 0001437749-26-025922 000-19672 261243562 34 7995645 1 1
2026-08-05 8-K FORM 8-K 2.02,5.07,9.01 0001437749-26-025921 000-19672 261243449 34 487931 1 1
2026-07-31 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-001340 005-41994 261225862 34 7446
2026-06-18 ARS ARS 0001193125-26-275845 000-19672 261102594 34 1829885
2026-06-18 DEFA14A DEFA14A 0001193125-26-275831 000-19672 261102561 34 355830
2026-06-18 DEF 14A DEF 14A 0001193125-26-275809 000-19672 261102519 34 3258954 1 1
2026-06-12 4 4 0001193125-26-269433 4902
2026-06-11 144 xsl144X01/primary_doc.xml 0001950047-26-005955 000-19672 261083634 33 6799
2026-06-11 4 4 0001193125-26-267677 8354
2026-06-11 4 4 0001193125-26-267642 8382
2026-06-11 144 xsl144X01/primary_doc.xml 0001950047-26-005923 000-19672 261083295 33 6869
2026-06-10 4 4 0001193125-26-265996 8352
2026-06-10 4 4 0001193125-26-265990 8381
2026-06-10 144 xsl144X01/primary_doc.xml 0001949846-26-000370 000-19672 261079081 33 4692
2026-06-08 144 xsl144X01/primary_doc.xml 0001950047-26-005745 000-19672 261072883 33 6113
2026-06-08 144 xsl144X01/primary_doc.xml 0001950047-26-005744 000-19672 261072873 33 6179
2026-06-03 144 xsl144X01/primary_doc.xml 0001950047-26-005559 000-19672 261060954 33 5492
2026-06-03 144 xsl144X01/primary_doc.xml 0001950047-26-005556 000-19672 261060934 33 5427
2026-06-03 4 4 0001193125-26-255471 19252
2026-06-03 4 4 0001193125-26-255450 20695
2026-06-02 144 xsl144X01/primary_doc.xml 0001950047-26-005517 000-19672 261057097 33 4744
2026-06-02 144 xsl144X01/primary_doc.xml 0001950047-26-005472 000-19672 261055983 33 4805
2026-06-02 8-K FORM 8-K 5.02,9.01 0001437749-26-019163 000-19672 261055918 34 175558 1 1
2026-05-29 SD FORM SD 0001437749-26-018910 000-19672 261046032 34 629149
2026-05-27 10-K FORM 10-K 0001437749-26-018542 000-19672 261026227 34 13539395 1 1
2026-05-27 8-K FORM 8-K 2.02,9.01 0001437749-26-018539 000-19672 261026171 34 519588 1 1
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-000109 005-41994 26916900 34 7313
2026-04-07 4 4 0001193125-26-145815 4928
2026-04-07 4 4 0001193125-26-145810 4951
2026-04-07 4 4 0001193125-26-145803 4975
2026-04-07 4 4 0001193125-26-145799 4965
2026-04-07 4 4 0001193125-26-145795 4952
2026-04-07 4 4 0001193125-26-145787 5021
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000605 005-41994 26797675 34 7084
2026-02-26 4 4 0001193125-26-077349 4693
2026-02-17 8-K/A FORM 8-K/A 9.01 0001437749-26-004349 000-19672 26641087 34 2622525 1 1
2026-02-04 10-Q FORM 10-Q 0001437749-26-002978 000-19672 26598286 34 9796097 1 1
2026-02-04 8-K FORM 8-K 2.02,9.01 0001437749-26-002977 000-19672 26598245 34 530654 1 1
2026-01-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-26-000102 005-41994 26581918 34 6920
2025-12-23 8-K 8-K 8.01,9.01 0001193125-25-330930 000-19672 251600648 34 161012 1 1
2025-12-23 424B7 424B7 0001193125-25-330851 333-281496 251600531 33 460957 1 1
2025-12-10 8-K 8-K 1.01,2.01,3.02,8.01,9.01 0001193125-25-314153 000-19672 251561967 34 1086699 1 1
2025-11-13 4 4 0001193125-25-280371 4523
2025-11-05 10-Q FORM 10-Q 0001437749-25-033351 000-19672 251454136 34 8814707 1 1
2025-11-05 8-K FORM 8-K 2.02,9.01 0001437749-25-033344 000-19672 251454019 34 526131 1 1
2025-08-08 144 xsl144X01/primary_doc.xml 0001969223-25-000589 000-19672 251198795 33 4273
2025-08-08 4 4 0000950170-25-105858 8499
2025-08-06 4 4 0000950170-25-104155 4538
2025-08-06 4 4 0000950170-25-104149 7884
2025-08-06 4 4 0000950170-25-104131 8599
2025-08-04 144 xsl144X01/primary_doc.xml 0001950047-25-005417 000-19672 251180742 33 12865
2025-08-04 144 xsl144X01/primary_doc.xml 0001950047-25-005392 000-19672 251180362 33 9764
2025-07-30 10-Q FORM 10-Q 0001437749-25-023968 000-19672 251167079 34 7392707 1 1
2025-07-30 8-K FORM 8-K 2.02,9.01 0001437749-25-023965 000-19672 251167041 34 456218 1 1
2025-07-29 8-K FORM 8-K 5.07,9.01 0001437749-25-023783 000-19672 251161941 34 173062 1 1
2025-06-13 ARS ARS 0001193125-25-140753 000-19672 251046643 34 14651265
2025-06-13 DEFA14A DEFA14A 0001193125-25-140738 000-19672 251046558 34 364287
2025-06-13 DEF 14A DEF 14A 0001193125-25-140726 000-19672 251046484 34 3952560 1 1
2025-06-12 4 4 0000950170-25-085421 7859
2025-06-12 4 4 0000950170-25-085408 8327
2025-06-11 8-K FORM 8-K 8.01,9.01 0001193125-25-139243 000-19672 251040747 34 424948 1 1
2025-06-11 424B5 424B5 0001193125-25-139239 333-281496 251040730 33 535388 1 1
2025-06-11 144 xsl144X01/primary_doc.xml 0001950047-25-004129 000-19672 251039902 33 6816
2025-06-11 144 xsl144X01/primary_doc.xml 0001950047-25-004127 000-19672 251039899 33 7559
2025-06-10 424B5 424B5 0001193125-25-138450 333-281496 251037116 33 410489
2025-06-09 4 4 0000950170-25-083826 6423
2025-06-09 4 4 0000950170-25-083818 6413
2025-06-06 144 xsl144X01/primary_doc.xml 0001950047-25-003943 000-19672 251030669 33 6869
2025-06-06 144 xsl144X01/primary_doc.xml 0001950047-25-003942 000-19672 251030662 33 6126
2025-05-29 4 4 0000950170-25-079169 8193
2025-05-29 4 4 0000950170-25-079157 8059
2025-05-29 4 4 0000950170-25-079138 5252
2025-05-29 3 3 0000950170-25-079129 20494
2025-05-27 144 xsl144X01/primary_doc.xml 0001950047-25-003445 000-19672 25988320 33 5495
2025-05-27 144 xsl144X01/primary_doc.xml 0001950047-25-003441 000-19672 25988159 33 5438
2025-05-22 4 4 0000950170-25-076416 6423
2025-05-22 4 4 0000950170-25-076404 6412
2025-05-21 SD FORM SD 0001437749-25-018002 000-19672 25973645 34 430267
2025-05-21 10-K FORM 10-K 0001437749-25-017986 000-19672 25973368 34 10980958 1 1
2025-05-21 8-K FORM 8-K 2.02,5.02,9.01 0001437749-25-017983 000-19672 25973044 34 548542 1 1
2025-05-20 144 xsl144X01/primary_doc.xml 0001950047-25-003240 000-19672 25968794 33 4744
2025-05-20 144 xsl144X01/primary_doc.xml 0001950047-25-003239 000-19672 25968779 33 4801
2025-05-19 4 4 0000950170-25-074461 5857
2025-05-19 4 4 0000950170-25-074454 5848
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000693 005-41994 25844654 34 10970
2025-04-04 4 4 0000950170-25-051189 4814
2025-04-04 4 4 0000950170-25-051187 4838
2025-04-04 4 4 0000950170-25-051186 4828
2025-04-04 4 4 0000950170-25-051183 4815
2025-04-04 4 4 0000950170-25-051168 4884
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001088875-25-000024 005-41994 25612934 34 6969
2025-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001507 005-41994 25594548 34 11996
2025-02-05 8-K FORM 8-K 2.02,5.03,9.01 0001437749-25-002901 000-19672 25593337 34 791463 1 1
2025-02-05 10-Q FORM 10-Q 0001437749-25-002900 000-19672 25593293 34 9116468 1 1
2024-11-12 SC 13G/A UnitedStates_13G__AmericanSu.txt 0000932471-24-000909 005-41994 241446605 34 6516
2024-11-08 SC 13G us0301112076_110824.txt 0002012383-24-003644 005-41994 241439786 34 13837
2024-11-06 4 4 0000950170-24-122413 5980
2024-11-05 144 xsl144X01/primary_doc.xml 0001972362-24-001482 000-19672 241428398 33 6833
2024-11-04 SC 13G UnitedStates_13G__AmericanSu.txt 0000932471-24-000274 005-41994 241421386 34 5563
2024-11-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001088875-24-000106 005-41994 241421164 34 7525
2024-10-30 10-Q FORM 10-Q 0001437749-24-032618 000-19672 241410487 34 8828402 1 1
2024-10-30 8-K FORM 8-K 2.02,9.01 0001437749-24-032617 000-19672 241410441 34 521996 1 1
2024-10-22 SC 13G us0301112076_102224.txt 0002012383-24-001660 005-41994 241387386 34 13825
2024-10-01 4 4 0000950170-24-110883 5865
2024-09-30 4 4 0000950170-24-110427 5876
2024-08-28 S-8 S-8 0001193125-24-208843 333-281826 241255955 33 79666
2024-08-13 8-K 8-K 8.01,9.01 0001193125-24-199141 000-19672 241198456 34 168274 1 1
2024-08-12 424B7 424B7 0001193125-24-199010 333-281496 241198014 33 501012
2024-08-12 S-3ASR S-3ASR 0001193125-24-198982 333-281496 241197873 33 652552
2024-08-09 SC 13G/A AMSC 13G/A 0001535264-24-000048 005-41994 241193277 34 9244
2024-08-06 8-K/A FORM 8-K/A 9.01 0001437749-24-024924 000-19672 241179981 34 1881106 1 1
2024-08-06 10-Q FORM 10-Q 0001437749-24-024886 000-19672 241179322 34 7319233 1 1
2024-08-06 8-K FORM 8-K 2.02,9.01 0001437749-24-024881 000-19672 241179240 34 453423 1 1
2024-08-05 8-K 8-K 5.02,5.07,9.01 0001193125-24-193965 000-19672 241175238 34 293892 1 1
2024-08-05 8-K 8-K 1.01,2.01,8.01,9.01 0001193125-24-193425 000-19672 241173259 34 783821 1 1
2024-06-20 ARS ARS 0001193125-24-164457 000-19672 241056379 34 1202176
2024-06-20 DEFA14A DEFA14A 0001193125-24-164450 000-19672 241056271 34 131598
2024-06-20 DEF 14A DEF 14A 0001193125-24-164444 000-19672 241056215 34 1161791
2024-06-12 4 4 0000950170-24-072273 6419
2024-06-12 4 4 0000950170-24-072272 6196
2024-06-11 144 xsl144X01/primary_doc.xml 0001950047-24-004598 000-19672 241035999 33 6089
2024-06-11 144 xsl144X01/primary_doc.xml 0001950047-24-004595 000-19672 241035908 33 6033
2024-06-10 PRE 14A PRE 14A 0001193125-24-158370 000-19672 241033179 34 1123634
2024-05-29 10-K FORM 10-K 0001437749-24-018602 000-19672 24999060 34 9684486 1 1
2024-05-29 8-K FORM 8-K 2.02,5.02,9.01 0001437749-24-018599 000-19672 24998990 34 524882 1 1
2024-05-28 SD FORM SD 0001437749-24-018462 000-19672 24991971 34 633596
2024-05-23 4 4 0000950170-24-063992 8060
2024-05-23 4 4 0000950170-24-063979 8321
2024-05-21 144 xsl144X01/primary_doc.xml 0001950047-24-003982 000-19672 24969597 33 5396
2024-05-21 144 xsl144X01/primary_doc.xml 0001950047-24-003981 000-19672 24969576 33 5338
2024-04-04 4 4 0000950170-24-041906 4879
2024-04-04 4 4 0000950170-24-041905 4810
2024-04-04 4 4 0000950170-24-041903 4823
2024-04-04 4 4 0000950170-24-041901 4833
2024-04-04 4 4 0000950170-24-041899 4809
2024-03-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-03-15 16:30:00 9999999995-24-000669 333-276766 24756797 33 1728
2024-03-13 CORRESP filename1.htm 0001193125-24-066810 7146
2024-03-08 S-3/A S-3/A 0001193125-24-063702 333-276766 24734990 33 68348
2024-03-06 CORRESP filename1.htm 0001193125-24-060045 7173
2024-03-05 CORRESP filename1.htm 0001193125-24-058784 7166
2024-02-14 SC 13G/A AMSC 13G/A 0001535264-24-000022 005-41994 24636314 34 9251
2024-02-05 UPLOAD filename1.pdf 0000000000-24-001366 333-276766 40305
2024-01-31 424B5 424B5 0001193125-24-021029 333-253611 24583668 33 444563
2024-01-31 8-K 8-K 8.01,9.01 0001193125-24-020938 000-19672 24583179 34 433504 1 1
2024-01-30 424B5 424B5 0001193125-24-019438 333-253611 24578492 33 443097
2024-01-30 S-3 S-3 0001193125-24-019425 333-276766 24578376 33 686513
2024-01-30 SC 13G/A amsc1.txt 0000906304-24-000048 005-41994 24577050 34 10984
2024-01-30 SC 13G/A AmericanSupercond29122023.txt 0001088875-24-000058 005-41994 24575806 34 11258
2024-01-24 10-Q FORM 10-Q 0001437749-24-002041 000-19672 24556487 34 7752258 1 1
2024-01-24 8-K FORM 8-K 2.02,9.01 0001437749-24-002040 000-19672 24556466 34 471339 1 1
2023-11-01 10-Q FORM 10-Q 0001437749-23-029753 000-19672 231368346 34 7542054 1 1
2023-11-01 8-K FORM 8-K 2.02,9.01 0001437749-23-029749 000-19672 231368268 34 469137 1 1
2023-08-11 8-K FORM 8-K 5.07 0001437749-23-023329 000-19672 231164222 34 174212 1 1
2023-08-09 10-Q FORM 10-Q 0001437749-23-022793 000-19672 231155234 34 6580090 1 1
2023-08-09 8-K FORM 8-K 2.02,9.01 0001437749-23-022786 000-19672 231155164 34 419417 1 1
2023-07-05 SC 13G/A AmericanSupercond30062023.txt 0001088875-23-000092 005-41994 231066770 34 10739
2023-06-28 ARS ARS 0001193125-23-177521 000-19672 231052312 34 1323664
2023-06-28 DEFA14A DEFA14A 0001193125-23-177515 000-19672 231052293 34 134819
2023-06-28 DEF 14A DEF 14A 0001193125-23-177510 000-19672 231052274 34 1020358
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039376 8512
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039350 8700
2023-06-22 144 xsl144X01/primary_doc.xml 0001950047-23-001870 000-19672 231034104 33 5326
2023-06-22 144 xsl144X01/primary_doc.xml 0001950047-23-001869 000-19672 231034092 33 6448
2023-06-21 144 xsl144X01/primary_doc.xml 0001950047-23-001855 000-19672 231030721 33 5227
2023-06-21 144 xsl144X01/primary_doc.xml 0001950047-23-001852 000-19672 231030612 33 5170
2023-06-21 8-K 8-K 5.02,9.01 0001193125-23-171201 000-19672 231030293 34 160235 1 1
2023-06-20 4 FORM 4 SUBMISSION 0001209191-23-038394 8255
2023-06-20 4 FORM 4 SUBMISSION 0001209191-23-038383 8251
2023-05-31 10-K FORM 10-K 0001437749-23-016265 000-19672 23981121 34 10177754 1 1
2023-05-31 8-K FORM 8-K 2.02,9.01 0001437749-23-016264 000-19672 23981110 34 494158 1 1
2023-05-31 SD FORM SD 0001437749-23-016150 000-19672 23978183 34 4849068
2023-04-07 4 FORM 4 SUBMISSION 0001209191-23-023781 4960
2023-04-07 4 FORM 4 SUBMISSION 0001209191-23-023776 4970
2023-04-07 4 FORM 4 SUBMISSION 0001209191-23-023769 4968
2023-04-07 4 FORM 4 SUBMISSION 0001209191-23-023766 4983
2023-04-07 4 FORM 4 SUBMISSION 0001209191-23-023763 4959
2023-02-14 SC 13G AMSC 13G 0001535264-23-000010 005-41994 23624365 34 9141
2023-02-08 SC 13G/A SEC SCHEDULE 13G 0000914208-23-000148 005-41994 23596545 34 17996
2023-02-01 10-Q FORM 10-Q 0001437749-23-002270 000-19672 23577658 34 8606707 1 1
2023-02-01 8-K FORM 8-K 2.02,9.01 0001437749-23-002268 000-19672 23577643 34 476126 1 1
2023-01-31 SC 13G amsc.txt 0000906304-23-000063 005-41994 23570750 34 10892
2023-01-19 SC 13G/A AmericanSupercond30122022.txt 0001088875-23-000021 005-41994 23536606 34 11176
2022-12-19 4 FORM 4 SUBMISSION 0001209191-22-061904 6094
2022-12-19 4 FORM 4 SUBMISSION 0001209191-22-061893 6105
2022-12-13 4 FORM 4 SUBMISSION 0001209191-22-060921 6106
2022-11-17 S-8 POS S-8 POS 0001193125-22-287778 333-233531 221399290 33 82802
2022-11-17 S-8 POS S-8 POS 0001193125-22-287772 333-213850 221399285 33 82802
2022-11-17 S-8 POS S-8 POS 0001193125-22-287767 333-197971 221399276 33 82802
2022-11-17 S-8 POS S-8 POS 0001193125-22-287752 333-183075 221399218 33 82802
2022-11-17 S-8 POS S-8 POS 0001193125-22-287748 333-170286 221399212 33 82802
2022-11-17 S-8 POS S-8 POS 0001193125-22-287744 333-145685 221399207 33 82802
2022-11-02 4 FORM 4 SUBMISSION 0001209191-22-055316 5978
2022-11-01 10-Q FORM 10-Q 0001437749-22-025367 000-19672 221350274 34 8418805 1 1
2022-11-01 8-K FORM 8-K 2.02,9.01 0001437749-22-025365 000-19672 221350254 34 473289 1 1
2022-10-21 4 FORM 4 SUBMISSION 0001209191-22-054266 6034
2022-08-10 S-8 S-8 0001193125-22-216468 333-266728 221150092 33 64910
2022-08-10 S-8 S-8 0001193125-22-216467 333-266727 221150089 33 93031
2022-08-05 8-K 8-K 5.02,5.07,9.01 0001193125-22-213651 000-19672 221141297 34 425335 1 1
2022-08-03 10-Q FORM 10-Q 0001437749-22-018630 000-19672 221132753 34 7624345 1 1
2022-08-03 8-K FORM 8-K 2.02,9.01 0001437749-22-018628 000-19672 221132724 34 425933 1 1
2022-07-26 DEFA14A DEFA14A 0001193125-22-201602 000-19672 221105050 34 11637
2022-07-08 SC 13G us0301112076_070822.txt 0000834237-22-010258 005-41994 221075002 34 12116
2022-06-23 DEFA14A DEFA14A 0001193125-22-180151 000-19672 221035654 34 133479
2022-06-23 DEF 14A DEF 14A 0001193125-22-180073 000-19672 221035542 34 773649
2022-06-14 4 FORM 4 SUBMISSION 0001209191-22-036623 5401
2022-06-14 4 FORM 4 SUBMISSION 0001209191-22-036620 5402
2022-06-13 3 FORM 3 SUBMISSION 0001209191-22-036416 6674
2022-06-13 3 FORM 3 SUBMISSION 0001209191-22-036413 6669
2022-06-13 4 FORM 4 SUBMISSION 0001209191-22-036360 6832
2022-06-13 4 FORM 4 SUBMISSION 0001209191-22-036351 6844
2022-06-13 4 FORM 4 SUBMISSION 0001209191-22-036335 4951
2022-06-10 8-K FORM 8-K 5.02,9.01 0001437749-22-014780 000-19672 221009006 34 189588 1 1
2022-06-02 4 FORM 4 SUBMISSION 0001209191-22-033666 6390
2022-06-02 4 FORM 4 SUBMISSION 0001209191-22-033662 6403
2022-06-01 10-K FORM 10-K 0001437749-22-014035 000-19672 22987449 34 10542807 1 1
2022-06-01 8-K FORM 8-K 2.02,9.01 0001437749-22-014033 000-19672 22987380 34 483415 1 1
2022-05-23 SD FORM SD 0001437749-22-013309 000-19672 22951687 34 5969272
2022-04-06 4 FORM 4 SUBMISSION 0001209191-22-023535 4927
2022-04-06 4 FORM 4 SUBMISSION 0001209191-22-023532 4926
2022-04-06 4 FORM 4 SUBMISSION 0001209191-22-023530 4950
2022-04-06 4 FORM 4 SUBMISSION 0001209191-22-023528 4877
2022-02-14 SC 13G SC 13G 0001193125-22-039174 005-41994 22624922 34 41999
2022-02-09 SC 13G/A SEC SCHEDULE 13G 0000914208-22-000128 005-41994 22607310 34 18199
2022-02-02 10-Q FORM 10-Q 0001437749-22-002208 000-19672 22583693 34 8485287 1 1
2022-02-02 8-K FORM 8-K 2.02,9.01 0001437749-22-002207 000-19672 22583651 34 468768 1 1
2022-02-01 SC 13G/A us0301112076_020122.txt 0000834237-22-004577 005-41994 22580009 34 13091
2022-01-18 SC 13G AmericanSupercond31122021.txt 0001088875-22-000017 005-41994 22533629 34 11145
2021-12-13 4 FORM 4 SUBMISSION 0001209191-21-069270 6068
2021-12-09 4 FORM 4 SUBMISSION 0001209191-21-068824 5216
2021-11-08 10-Q FORM 10-Q 0001437749-21-025699 000-19672 211388093 34 8276480 1 1
2021-11-08 8-K FORM 8-K 2.02,9.01 0001437749-21-025697 000-19672 211388043 34 468439 1 1
2021-11-02 4 FORM 4 SUBMISSION 0001209191-21-062404 6418
2021-11-02 4 FORM 4 SUBMISSION 0001209191-21-062400 10122
2021-08-06 4 FORM 4 SUBMISSION 0001209191-21-050089 6226
2021-08-06 4 FORM 4 SUBMISSION 0001209191-21-050087 6241
2021-08-04 10-Q FORM 10-Q 0001437749-21-018523 000-19672 211144175 34 7501248 1 1
2021-08-04 8-K FORM 8-K 2.02,9.01 0001437749-21-018522 000-19672 211144101 34 429454 1 1
2021-08-02 8-K 8-K 5.07 0001193125-21-233260 000-19672 211136226 34 21963
2021-07-06 4 FORM 4 SUBMISSION 0001209191-21-045578 6412
2021-07-06 4 FORM 4 SUBMISSION 0001209191-21-045570 6423
2021-06-21 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-21-179941,2021-06-21 9999999995-21-002417 333-253611 211032954 33 1693
2021-06-17 DEFA14A DEFA14A 0001193125-21-193240 000-19672 211025175 34 444004
2021-06-17 DEF 14A DEF 14A 0001193125-21-193232 000-19672 211025135 34 1059040
2021-06-02 POS AM POS AM 0001193125-21-179941 333-253611 21989678 33 361307
2021-06-02 10-K FORM 10-K 0001437749-21-013956 000-19672 21989260 34 10190276 1
2021-06-02 8-K FORM 8-K 2.02,9.01 0001437749-21-013955 000-19672 21989225 34 335135
2021-06-02 POSASR POSASR 0001193125-21-179834 333-253611 21989118 33 358254
2021-05-27 SD FORM SD 0001437749-21-013534 000-19672 21972783 34 606933
2021-05-25 8-K FORM 8-K 5.02,9.01 0001437749-21-013279 000-19672 21960716 34 40885
2021-05-24 4 FORM 4 SUBMISSION 0001209191-21-035472 8322
2021-05-24 4 FORM 4 SUBMISSION 0001209191-21-035469 8332
2021-05-21 8-K FORM 8-K 8.01,9.01 0001193125-21-168626 000-19672 21946650 34 40140
2021-05-21 424B7 424B7 0001193125-21-168623 333-253611 21946647 33 430798
2021-05-10 8-K 8-K 1.01,9.01 0001193125-21-156251 000-19672 21907407 34 674166
2021-04-07 4 FORM 4 SUBMISSION 0001209191-21-025808 4926
2021-04-07 4 FORM 4 SUBMISSION 0001209191-21-025805 4948
2021-04-07 4 FORM 4 SUBMISSION 0001209191-21-025803 4927
2021-04-07 4 FORM 4 SUBMISSION 0001209191-21-025802 4877
2021-02-26 S-3ASR S-3ASR 0001193125-21-060535 333-253611 21689361 33 598034
2021-02-26 8-K 8-K 8.01,9.01 0001193125-21-060434 000-19672 21689011 34 82925
2021-02-16 SC 13G SEC SCHEDULE 13G 0000914208-21-000296 005-41994 21637029 34 23906
2021-02-10 SC 13G/A amsc-13g_20201231.txt 0001037389-21-000063 005-41994 21613451 34 13310
2021-02-03 10-Q FORM 10-Q 0001437749-21-001877 000-19672 21586562 34 7651513 1
2021-02-03 8-K FORM 8-K 2.02,9.01 0001437749-21-001859 000-19672 21586247 34 341661
2021-02-01 8-K FORM 8-K 5.03,9.01 0001437749-21-001681 000-19672 21577019 34 200592
2021-01-29 SC 13G/A us0301112076_012821.txt 0000834237-21-003046 005-41994 21566991 34 13072
2021-01-22 4 FORM 4 SUBMISSION 0001209191-21-004891 10294
2021-01-08 SC 13G/A AMERICAN SUPERCONDUCTOR 13G/A 0001535264-21-000002 005-41994 21517758 34 9275
2020-12-14 8-K/A FORM 8-K/A 9.01 0001437749-20-025291 000-19672 201386248 34 881648
2020-11-30 4 FORM 4 SUBMISSION 0001209191-20-060763 6183
2020-11-04 10-Q FORM 10-Q 0001437749-20-022522 000-19672 201286735 34 6129558 1
2020-11-04 8-K FORM 8-K 2.02,9.01 0001437749-20-022520 000-19672 201286702 34 332789
2020-11-02 4 FORM 4 SUBMISSION 0001209191-20-056421 7748
2020-11-02 4 FORM 4 SUBMISSION 0001209191-20-056419 5918
2020-10-26 8-K 8-K 8.01,9.01 0001193125-20-276900 000-19672 201260746 34 234263
2020-10-23 424B5 424B5 0001193125-20-275422 333-222874 201257767 33 404557
2020-10-21 424B5 424B5 0001193125-20-273637 333-222874 201250592 33 405446
2020-10-05 8-K FORM 8-K 2.02 0001437749-20-020735 000-19672 201223625 34 25895
2020-10-05 8-K FORM 8-K 1.01,2.01,3.02,9.01 0001437749-20-020734 000-19672 201223608 34 441644
2020-10-02 8-K FORM 8-K 8.01 0001437749-20-020660 000-19672 201219629 34 27204
2020-09-16 8-K FORM 8-K 8.01 0001437749-20-019767 000-19672 201178967 34 31208
2020-08-05 10-Q FORM 10-Q 0001437749-20-016667 000-19672 201077569 34 4823345 1
2020-08-05 8-K FORM 8-K 2.02,5.07,9.01 0001437749-20-016665 000-19672 201077511 34 293677
2020-07-29 4 FORM 4 SUBMISSION 0001209191-20-043970 5913
2020-07-29 4 FORM 4 SUBMISSION 0001209191-20-043968 5925
2020-06-30 4 FORM 4 SUBMISSION 0001209191-20-039510 5913
2020-06-30 4 FORM 4 SUBMISSION 0001209191-20-039507 5925
2020-06-19 DEFA14A DEFA14A 0001193125-20-174036 000-19672 20975874 34 526299
2020-06-19 DEF 14A DEF 14A 0001193125-20-174030 000-19672 20975812 34 1169961
2020-06-19 SC 13G/A SC 13G/A 0001193125-20-174006 005-41994 20975669 34 153582
2020-06-04 4 FORM 4 SUBMISSION 0001209191-20-034474 7937
2020-06-04 4 FORM 4 SUBMISSION 0001209191-20-034461 7949
2020-06-02 10-K FORM 10-K 0001437749-20-012276 000-19672 20937078 34 9163107 1
2020-06-02 8-K FORM 8-K 2.02,9.01 0001437749-20-012274 000-19672 20937028 34 355160
2020-05-27 8-K FORM 8-K 5.02,9.01 0001437749-20-011837 000-19672 20915426 34 49091
2020-05-26 4 FORM 4 SUBMISSION 0001209191-20-032045 6012
2020-05-26 4 FORM 4 SUBMISSION 0001209191-20-032025 6025
2020-05-26 SD FORM SD 0001437749-20-011739 000-19672 20910729 34 489144
2020-04-07 4 FORM 4 SUBMISSION 0001209191-20-023750 8749
2020-04-07 4 FORM 4 SUBMISSION 0001209191-20-023749 8754
2020-04-07 4 FORM 4 SUBMISSION 0001209191-20-023748 8669
2020-04-07 4 FORM 4 SUBMISSION 0001209191-20-023747 8768
2020-02-13 SC 13G/A SC 13G/A 0001193125-20-033720 005-41994 20606755 34 43313
2020-02-12 SC 13G/A AMERICAN SUPERCONDUCTOR 13G/A 0001535264-20-000013 005-41994 20602975 34 9293
2020-02-12 SC 13G amsc-13g_20191231.txt 0001037389-20-000006 005-41994 20601239 34 13315
2020-02-07 SC 13G us0301112076_020620.txt 0000834237-20-008226 005-41994 20584870 34 13020
2020-02-05 10-Q FORM 10-Q 0001437749-20-001789 000-19672 20578824 34 7209105 1
2020-02-05 8-K FORM 8-K 2.02,9.01 0001437749-20-001788 000-19672 20578798 34 356619
2020-02-04 SC 13G/A AMSC_SC13GA1.htm 0001319244-20-000033 005-41994 20574634 34 166418
2020-01-27 SC 13G SC 13G 0001193125-20-015377 005-41994 20549707 34 140667
2019-12-23 4 FORM 4 SUBMISSION 0001209191-19-061821 6332
2019-11-07 4 FORM 4 SUBMISSION 0001209191-19-055708 6163
2019-11-07 4 FORM 4 SUBMISSION 0001209191-19-055700 6177
2019-11-05 10-Q FORM 10-Q 0001437749-19-021592 000-19672 191193588 34 6885895 1
2019-11-05 8-K FORM 8-K 2.02,9.01 0001437749-19-021590 000-19672 191193416 34 346778
2019-11-04 4 FORM 4 SUBMISSION 0001209191-19-054980 5980
2019-11-04 4 FORM 4 SUBMISSION 0001209191-19-054966 7808
2019-08-29 S-8 S-8 0001193125-19-234127 333-233531 191067004 33 59398
2019-08-06 8-K 8-K 5.02,5.07,9.01 0001193125-19-214189 000-19672 191002927 34 134844
2019-08-06 10-Q FORM 10-Q 0001437749-19-015632 000-19672 191002181 34 5829970 1
2019-08-06 8-K FORM 8-K 2.02,9.01 0001437749-19-015631 000-19672 191002124 34 278585
2019-07-30 4 FORM 4 SUBMISSION 0001209191-19-043711 5904
2019-07-30 4 FORM 4 SUBMISSION 0001209191-19-043707 5916
2019-07-02 4 FORM 4 SUBMISSION 0001209191-19-040480 5903
2019-07-02 4 FORM 4 SUBMISSION 0001209191-19-040283 5915
2019-06-24 SC 13G AMSC_SC13G.htm 0001319244-19-000055 005-41994 19915587 34 171327
2019-06-20 DEFA14A DEFA14A 0001193125-19-177543 000-19672 19908900 34 60353
2019-06-20 DEF 14A DEF 14A 0001193125-19-177535 000-19672 19908887 34 791176
2019-06-05 10-K FORM 10-K 0001437749-19-011477 000-19672 19879852 34 9106286 1
2019-06-05 8-K FORM 8-K 2.02,5.02,9.01 0001437749-19-011476 000-19672 19879831 34 435312
2019-05-30 SD FORM SD 0001437749-19-011068 000-19672 19866724 34 645563
2019-05-30 CT ORDER filename1.pdf 20190530,20190530 9999999997-19-005280 000-19672 19865005 34 10658
2019-05-29 4 FORM 4 SUBMISSION 0001209191-19-033254 5226
2019-05-29 3 FORM 3 SUBMISSION 0001209191-19-033246 2885
2019-05-24 4 FORM 4 SUBMISSION 0001209191-19-032723 4892
2019-05-24 8-K FORM 8-K 5.02 0001437749-19-010833 000-19672 19854661 34 22923
2019-05-14 4 FORM 4 SUBMISSION 0001209191-19-029676 5915
2019-04-04 4 FORM 4 SUBMISSION 0001209191-19-023674 4782
2019-04-04 4 FORM 4 SUBMISSION 0001209191-19-023672 4832
2019-04-04 4 FORM 4 SUBMISSION 0001209191-19-023671 4809
2019-04-04 4 FORM 4 SUBMISSION 0001209191-19-023668 4831
2019-02-14 SC 13G SC 13G 0001193125-19-041082 005-41994 19607916 34 59388
2019-02-13 SC 13G/A SCHEDULE 13G/A (AMENDMENT NO. 1) 0001193125-19-038123 005-41994 19598024 34 44983
2019-02-13 SC 13G/A AMERICAN SUPERCONDUCTOR 13G/A 0001535264-19-000027 005-41994 19596003 34 9419
2019-02-13 CT ORDER filename1.pdf 20190213,20190213 9999999997-19-000298 000-19672 19595758 34 101344
2019-02-08 SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-19-000995 005-41994 19580415 34 112246
2019-02-08 SC 13G REPORT OF ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-19-000975 005-41994 19578696 34 99140
2019-02-05 10-Q 10-Q 0001628280-19-000966 000-19672 19568328 34 6882614 1
2019-02-05 8-K 8-K 2.02,8.01,9.01 0001628280-19-000964 000-19672 19568251 34 532638
2019-01-02 4 FORM 4 SUBMISSION 0001209191-19-000305 6329
2018-12-11 4 FORM 4 SUBMISSION 0001209191-18-062034 6281
2018-11-13 4 FORM 4 SUBMISSION 0001209191-18-058314 5910
2018-11-13 4 FORM 4 SUBMISSION 0001209191-18-058308 5924
2018-11-06 10-Q 10-Q 0001628280-18-013770 000-19672 181163118 34 6614561 1
2018-11-06 8-K 8-K 2.02,9.01 0001628280-18-013765 000-19672 181163032 34 530548
2018-11-05 4 FORM 4 SUBMISSION 0001209191-18-057267 5863
2018-10-31 8-K 8-K 1.01 0001628280-18-013204 000-19672 181151088 34 37429
2018-10-05 SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-18-005313 005-41994 181110230 34 109589
2018-08-30 CT ORDER filename1.pdf 20180830,20180830 9999999997-18-007535 000-19672 181047506 34 13946
2018-08-10 CT ORDER filename1.pdf 20180810,20180810 9999999997-18-007229 000-19672 181007655 34 14430
2018-08-10 CT ORDER filename1.pdf 20180810,20180810 9999999997-18-007225 000-19672 181007409 34 14372
2018-08-06 4 FORM 4 SUBMISSION 0001209191-18-045571 5904
2018-08-06 4 FORM 4 SUBMISSION 0001209191-18-045569 5918
2018-08-01 8-K 8-K 5.07 0001628280-18-010196 000-19672 18984907 34 43596
2018-07-31 10-Q 10-Q 0001628280-18-009847 000-19672 18981278 34 5662922 1
2018-07-31 8-K 8-K 2.02,9.01 0001628280-18-009846 000-19672 18981227 34 443485
2018-07-31 4 FORM 4 SUBMISSION 0001209191-18-044523 5909
2018-07-30 4 FORM 4 SUBMISSION 0001209191-18-044423 4914
2018-07-13 CT ORDER filename1.pdf 20180713,20180713 9999999997-18-006894 000-19672 18951735 34 17172
2018-07-09 8-K FORM 8-K 1.01,9.01 0001193125-18-214745 000-19672 18945015 34 6649230
2018-07-03 8-K 8-K 5.02,9.01 0001628280-18-009075 000-19672 18937335 34 62950
2018-07-02 4 FORM 4 SUBMISSION 0001209191-18-040434 5960
2018-07-02 4 FORM 4 SUBMISSION 0001209191-18-040338 5982
2018-06-15 DEFA14A DEFA14A 0001193125-18-194405 000-19672 18902039 34 58222
2018-06-15 DEF 14A DEF 14A 0001193125-18-194400 000-19672 18902028 34 568248
2018-06-14 8-K 8-K 5.02 0001628280-18-007877 000-19672 18899363 34 31689
2018-06-07 10-K/A 10-K/A 0001628280-18-007711 000-19672 18887124 34 316956
2018-06-06 10-K 10-K 0001628280-18-007644 000-19672 18883932 34 12804707 1
2018-06-06 8-K 8-K 2.02,9.01 0001628280-18-007643 000-19672 18883897 34 524294
2018-05-25 SD SD 0001628280-18-007199 000-19672 18861241 34 467674
2018-05-15 4 FORM 4 SUBMISSION 0001209191-18-030195 5905
2018-05-15 4 FORM 4 SUBMISSION 0001209191-18-030150 9577
2018-04-10 8-K 8-K 5.02 0001628280-18-004141 000-19672 18748309 34 33300
2018-04-06 4 FORM 4 SUBMISSION 0001209191-18-024177 8941
2018-04-06 4 FORM 4 SUBMISSION 0001209191-18-024174 8938
2018-04-06 4 FORM 4 SUBMISSION 0001209191-18-024171 8896
2018-04-06 4 FORM 4 SUBMISSION 0001209191-18-024169 4832
2018-04-06 4 FORM 4 SUBMISSION 0001209191-18-024165 8913
2018-04-03 8-K 8-K 2.01,9.01 0001628280-18-003952 000-19672 18733960 34 283773
2018-03-08 SC 13G SC 13G 0001193125-18-073935 005-41994 18674919 34 35880
2018-02-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2018-02-15 16:30:00 9999999995-18-000459 333-222874 18619584 33 1679
2018-02-13 UPLOAD filename1.pdf 0000000000-18-005004 36137
2018-02-13 SC 13G AMERICAN SUPERCONDUCTOR 13G 0001535264-18-000030 005-41994 18603214 34 9427
2018-02-13 CORRESP filename1.htm 0001193125-18-042418 7344
2018-02-09 4/A FORM 4/A SUBMISSION 0001209191-18-008890 5875
2018-02-09 4 FORM 4 SUBMISSION 0001209191-18-008757 5801

Latest XBRL company facts

One latest value per concept from companyfacts (544 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 48.46M 2026-10-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
dei EntityNumberOfEmployees Entity Number of Employees employee 225 2018-09-30 2018 Q2 10-Q 2018-11-06 0001628280-18-013770
dei EntityPublicFloat Entity Public Float USD 2.58B 2025-09-30 2026 FY 10-K 2026-05-27 0001437749-26-018542
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 299.15B 2024-04-01 2025-03-31 DEF 14A 2026-06-18 0001193125-26-275809
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 8.38M 2024-04-01 2025-03-31 DEF 14A 2026-06-18 0001193125-26-275809
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.79M 2024-04-01 2025-03-31 DEF 14A 2026-06-18 0001193125-26-275809
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 274.77 2024-04-01 2025-03-31 DEF 14A 2026-06-18 0001193125-26-275809
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 17.51M 2024-04-01 2025-03-31 DEF 14A 2026-06-18 0001193125-26-275809
ecd PeoTotalCompAmt PeoTotalCompAmt USD 7.53M 2024-04-01 2025-03-31 DEF 14A 2026-06-18 0001193125-26-275809
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 178.53 2024-04-01 2025-03-31 DEF 14A 2026-06-18 0001193125-26-275809
ecd TrdArrSecuritiesAggAvailAmt TrdArrSecuritiesAggAvailAmt shares 241,282 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
invest InvestmentWarrantsExercisePrice Investment Warrants, Exercise Price USD 9.41 2015-04-28 2015-04-29 2015 FY 10-K 2016-05-31 0001564590-16-020115
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 44.58M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 11.85M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 66.35M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 957,000 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 10.63M 2014-09-30 2014 Q2 10-Q 2014-11-06 0001564590-14-005096
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 290,000 2014-03-31 2014 FY 10-K 2015-05-28 0001564590-15-004664
us-gaap AccruedSalesCommissionCurrent Accrued Sales Commission, Current USD 2.40M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 42.42M 2021-03-31 2021 FY 10-K 2021-06-02 0001437749-21-013956
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 5.25M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 975.83M 2014-09-30 2014 Q2 10-Q 2014-11-06 0001564590-14-005096
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.49B 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD 1.33M 2008-04-01 2009-03-31 8-K 2012-04-13 0001193125-12-162694
us-gaap AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities USD -196,000 2013-04-01 2013-09-30 2014 Q2 10-Q 2014-11-06 0001564590-14-005096
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 6.52M 2026-07-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap AdjustmentsToAdditionalPaidInCapitalStockSplit Adjustments to Additional Paid in Capital, Stock Split USD 1,000 2014-04-01 2015-03-31 2016 FY 10-K 2017-05-25 0001628280-17-005885
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 11.78M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 15,000 2020-12-31 2021 Q3 10-Q 2021-02-03 0001437749-21-001877
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 54,000 2018-03-31 2018 FY 10-K 2019-06-05 0001437749-19-011477
us-gaap AmortizationOfAcquisitionCosts Amortization of Acquisition Costs USD 930,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 19,000 2017-04-01 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 0 2022-04-01 2023-03-31 2022 FY 10-K 2023-05-31 0001437749-23-016265
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 3.00M 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 680,922 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2023-04-01 2024-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap Assets Assets USD 774.66M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap AssetsCurrent Assets, Current USD 354.00M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap AssetsFairValueDisclosureNonrecurring Assets, Fair Value Disclosure, Nonrecurring (Deprecated 2018-01-31) USD 3.69M 2014-12-31 2014 FY 10-K 2015-05-28 0001564590-15-004664
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 5.28M 2012-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap AvailableForSaleSecuritiesFairValueDisclosure Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) USD 5.30M 2012-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap AvailableforsaleSecuritiesGrossUnrealizedGain Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) USD 28,000 2012-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap BilledContractReceivables Billed Contracts Receivable USD 54.34M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap BorrowedFunds Borrowed Funds (Deprecated 2014-01-31) USD 10.00M 2012-06-05 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap BusinessAcquisitionProFormaEarningsPerShareBasic Business Acquisition, Pro Forma Earnings Per Share, Basic USD/shares 0.31 2025-04-01 2025-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap BusinessAcquisitionProFormaEarningsPerShareDiluted Business Acquisition, Pro Forma Earnings Per Share, Diluted USD/shares 0.3 2025-04-01 2025-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax USD -33.02M 2022-04-01 2023-03-31 2022 FY 10-K 2023-05-31 0001437749-23-016265
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD 13.46M 2025-04-01 2025-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 118.03M 2025-04-01 2025-09-30 2026 Q2 10-Q 2025-11-05 0001437749-25-033351
us-gaap BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable Business Combination, Consideration Transferred, Equity Interests Issued and Issuable USD 3.50M 2017-04-01 2018-03-31 2018 FY 10-K 2019-06-05 0001437749-19-011477
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset USD 4.40M 2021-04-01 2021-12-31 2022 Q3 10-Q 2022-02-02 0001437749-22-002208
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 7.00M 2024-06-30 2026 Q2 10-Q 2025-11-05 0001437749-25-033351
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 6.19M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 24.30M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap BusinessExitCosts Business Exit Costs (Deprecated 2013-01-31) USD 300,000 2011-04-01 2012-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap BusinessExitCosts1 Business Exit Costs USD 300,000 2011-04-01 2012-03-31 2013 FY 10-K 2014-06-05 0001564590-14-002420
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 169.92M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 47.09M 2018-12-31 2018 Q3 10-Q 2019-02-05 0001628280-19-000966
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 7.30M 2017-04-01 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 74.14M 2020-12-31 2021 Q3 10-Q 2021-02-03 0001437749-21-001877
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 181.90M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 43.95M 2018-04-01 2019-03-31 2018 FY 10-K 2019-06-05 0001437749-19-011477
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 34.35M 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 22.18M 2014-06-30 2014 Q1 10-Q 2014-08-05 0001564590-14-003115
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/shares_unit 3.59 2012-06-05 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 139,000 2012-06-05 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 0 2020-12-31 2021 FY 10-K 2021-06-02 0001437749-21-013956
us-gaap CommercialPaperAtCarryingValue Commercial Paper, at Carrying Value USD 5.30M 2012-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 94,488 2013-11-19 2014 FY 10-K 2015-05-28 0001564590-15-004664
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 75.00M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 48.87M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 48.47M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap CommonStockValue Common Stock, Value, Issued USD 489,000 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap CommonUnitIssued Common Unit, Issued shares 909,090 2014-11-13 2015 FY 10-K 2016-05-31 0001564590-16-020115
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 13.66M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -40.03M 2014-04-01 2014-09-30 2014 Q2 10-Q 2014-11-06 0001564590-14-005096
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 109.59M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized USD 111.59M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 96.31M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination USD 19.78M 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 13.28M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD -95.33M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 5.88M 2013-03-31 2013 FY 10-K 2014-06-05 0001564590-14-002420
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 4.61M 2013-03-31 2013 FY 10-K 2014-06-05 0001564590-14-002420
us-gaap CostOfRevenue Cost of Revenue USD 136.85M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap CostsAndExpenses Costs and Expenses USD -29.11M 2018-04-01 2018-12-31 2018 Q3 10-Q 2019-02-05 0001628280-19-000966
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 33,000 2018-06-30 2019 Q1 10-Q 2019-08-06 0001437749-19-015632
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 36,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 569,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 1.62M 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 1.02M 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 179,000 2024-01-01 2024-06-30 2025 Q1 10-Q 2024-08-06 0001437749-24-024886
us-gaap DebtCurrent Debt, Current USD 1.62M 2025-12-31 2026 Q3 10-Q 2026-02-04 0001437749-26-002978
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 10.41M 2013-12-31 2014 FY 10-K 2015-05-28 0001564590-15-004664
us-gaap DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent Debt Instrument, Convertible, Carrying Amount of Equity Component USD 25.00M 2012-04-04 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 4.85 2012-04-04 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap DebtInstrumentConvertibleEffectiveInterestRate Debt Instrument, Convertible, Effective Interest Rate (Deprecated 2013-01-31) pure 0.07 2012-03-25 2012-04-04 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 35.00M 2012-06-30 2013 Q1 10-Q 2013-08-07 0001193125-13-324142
us-gaap DebtInstrumentIncreaseDecreaseOtherNet Debt Instrument, Increase (Decrease), Other, Net USD 14.60M 2013-04-01 2013-12-31 2013 Q3 10-Q 2014-02-06 0001564590-14-000165
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 2.80M 2012-06-30 2012 Q1 10-Q 2012-08-03 0001193125-12-334096
us-gaap DebtInstrumentUnamortizedDiscountCurrent Debt Instrument, Unamortized Discount, Current USD 19,000 2017-03-31 2017 Q3 10-Q 2018-02-05 0001628280-18-000993
us-gaap DebtInstrumentUnamortizedDiscountNoncurrent Debt Instrument, Unamortized Discount, Noncurrent USD 0 2016-12-31 2016 Q3 10-Q 2017-02-06 0001628280-17-000901
us-gaap DebtSecuritiesAvailableForSaleUnrealizedGainLoss Debt Securities, Available-for-sale, Unrealized Gain (Loss) USD 0 2022-04-01 2022-09-30 2022 Q2 10-Q 2022-11-01 0001437749-22-025367
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -116.95M 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -318,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap DeferredGainOnSaleOfProperty Deferred Gain on Sale of Property USD 105,000 2018-03-31 2018 FY 10-K 2019-06-05 0001437749-19-011477
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 117.29M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 2.21M 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 12.73M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 0 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap DeferredPolicyAcquisitionCostAmortizationExpense Deferred Policy Acquisition Costs, Amortization Expense USD 183,000 2017-04-01 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 13.48M 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 8.45M 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -1.42M 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 177.21M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap DeferredTaxAssetsGrossNoncurrent Deferred Tax Assets, Gross, Noncurrent USD 7.72M 2014-09-30 2014 Q2 10-Q 2014-11-06 0001564590-14-005096
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 12.16M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 119.47M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 132.20M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 203,000 2012-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 115,000 2016-12-31 2016 Q3 10-Q 2017-02-06 0001628280-17-000901
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 144.50M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 2.08M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 13.00M 2017-03-31 2016 FY 10-K 2017-05-25 0001628280-17-005885
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 13.70M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 45.01M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap DeferredTaxExpenseFromStockOptionsExercised Deferred Tax Expense from Stock Options Exercised USD 52.50M 2015-04-01 2016-03-31 2015 FY 10-K 2016-05-31 0001564590-16-020115
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 417,000 2025-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap DeferredTaxLiabilitiesCurrent Deferred Tax Liabilities, Net, Current USD 7.72M 2014-09-30 2014 Q2 10-Q 2014-11-06 0001564590-14-005096
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 6.40M 2024-12-31 2025 Q3 10-Q 2025-02-05 0001437749-25-002900
us-gaap DeferredTaxLiabilitiesGrossCurrent Deferred Tax Liabilities, Gross, Current USD 7.84M 2015-03-31 2015 FY 10-K 2016-05-31 0001564590-16-020115
us-gaap DeferredTaxLiabilitiesGrossNoncurrent Deferred Tax Liabilities, Gross, Noncurrent USD 63,000 2016-03-31 2015 FY 10-K 2016-05-31 0001564590-16-020115
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 203,000 2012-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 1.54M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap DeferredTaxLiabilitiesOtherFiniteLivedAssets Deferred Tax Liabilities, Other Finite-Lived Assets USD 2.30M 2021-09-30 2022 Q2 10-Q 2021-11-08 0001437749-21-025699
us-gaap DeferredTaxLiabilitiesUndistributedForeignEarnings Deferred Tax Liabilities, Undistributed Foreign Earnings USD 200,000 2020-03-31 2020 FY 10-K 2020-06-02 0001437749-20-012276
us-gaap DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries USD 400,000 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap DefinedBenefitPlanBenefitsPaid Defined Benefit Plan, Benefits Paid (Deprecated 2017-01-31) USD 2.00M 2011-04-01 2011-06-30 2011 Q1 10-Q 2011-09-23 0000950123-11-086250
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 1.90M 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap DepositLiabilityCurrent Deposit Liability, Current USD 2.29M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap Depreciation Depreciation USD 3.30M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap DepreciationAmortizationAndAccretionNet Depreciation, Amortization and Accretion, Net USD 11.00M 2017-04-01 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 5.23M 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 2.90M 2025-04-01 2025-12-31 2026 Q3 10-Q 2026-02-04 0001437749-26-002978
us-gaap DerivativeAssets Derivative Asset USD 3.09M 2011-03-31 2011 Q3 10-Q 2012-02-09 0001193125-12-048929
us-gaap DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure Derivative Financial Instruments, Liabilities, Fair Value Disclosure (Deprecated 2013-01-31) USD 500,000 2013-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap DerivativeInstrumentsLossRecognizedInIncome Derivative Instruments, Loss Recognized in Income (Deprecated 2013-01-31) USD 500,000 2012-10-01 2012-12-31 2012 Q3 10-Q 2013-02-11 0001193125-13-048834
us-gaap DerivativeLiabilities Derivative Liability USD 200,000 2013-09-30 2014 FY 10-K 2015-05-28 0001564590-15-004664
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 1.27M 2023-03-31 2022 FY 10-K 2023-05-31 0001437749-23-016265
us-gaap DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment Disposal Group, Including Discontinued Operation, Property, Plant and Equipment USD 22.40M 2018-03-28 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap DisposalGroupNotDiscontinuedOperationGainLossOnDisposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal USD 0 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-29 0001437749-24-018602
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.27 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.27 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.272 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 7.301 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 3.51 2017-04-01 2018-03-31 2018 FY 10-K 2019-06-05 0001437749-19-011477
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent pure -0.001 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap EffectiveIncomeTaxRateReconciliationDeductionsDividends Effective Income Tax Rate Reconciliation, Deduction, Dividend, Percent pure -0.07 2017-04-01 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.02 2024-04-01 2025-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure -0.015 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.12 2024-04-01 2025-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent pure 0.07 2010-04-01 2011-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.006 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure -0.01 2012-04-01 2013-03-31 2014 FY 10-K 2015-05-28 0001564590-15-004664
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.226 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.01 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent pure 0 2021-04-01 2022-03-31 2022 FY 10-K 2022-06-01 0001437749-22-014035
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure 0.54 2024-04-01 2025-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.036 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingenciesForeign Effective Income Tax Rate Reconciliation, Tax Contingency, Foreign, Percent pure 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.004 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0 2024-04-01 2025-03-31 2025 FY 10-K 2025-05-21 0001437749-25-017986
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlements Effective Income Tax Rate Reconciliation, Tax Settlement, Percent pure 0 2017-04-01 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -792,000 2018-04-01 2018-12-31 2018 Q3 10-Q 2019-02-05 0001628280-19-000966
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 73,000 2020-04-01 2020-12-31 2021 Q3 10-Q 2021-02-03 0001437749-21-001877
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -48,000 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 1.58M 2014-04-01 2014-06-30 2014 Q1 10-Q 2014-08-05 0001564590-14-003115
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 12.51M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap EmployeeStockOwnershipPlanESOPCompensationExpense Employee Stock Ownership Plan (ESOP), Compensation Expense USD 100,000 2014-04-01 2015-03-31 2015 FY 10-K 2016-05-31 0001564590-16-020115
us-gaap EquityMethodInvestmentOtherThanTemporaryImpairment Equity Method Investment, Other than Temporary Impairment USD 0 2017-04-01 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap EquityMethodInvestmentRealizedGainLossOnDisposal Equity Method Investment, Realized Gain (Loss) on Disposal USD 127,000 2018-04-01 2019-03-31 2020 FY 10-K 2020-06-02 0001437749-20-012276
us-gaap EquityMethodInvestments Equity Method Investments USD 1.43M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 4.65M 2019-04-01 2020-03-31 2021 FY 10-K 2021-06-02 0001437749-21-013956
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2017-07-01 2017-09-30 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.665 2017-07-01 2017-09-30 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.011 2017-07-01 2017-09-30 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap FairValueLevel1ToLevel2TransfersAmount Fair Value, Level 1 to level 2 Transfers, Amount (Deprecated 2012-01-31) USD 0 2011-10-01 2011-12-31 2011 Q3 10-Q 2012-02-09 0001193125-12-048929
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 9.45M 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 7.05M 2021-03-31 2021 FY 10-K 2021-06-02 0001437749-21-013956
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 13,200 2021-05-06 2022 Q3 10-Q 2022-02-02 0001437749-22-002208
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 0 2024-03-31 2024 FY 10-K 2024-05-29 0001437749-24-018602
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 0 2024-03-31 2024 FY 10-K 2024-05-29 0001437749-24-018602
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 0 2024-03-31 2024 FY 10-K 2024-05-29 0001437749-24-018602
us-gaap FinanceLeaseRightOfUseAssetAccumulatedAmortization Finance Lease, Right-of-Use Asset, Accumulated Amortization USD 12,200 2023-03-31 2022 FY 10-K 2023-05-31 0001437749-23-016265
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 17.70M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap FiniteLivedIntangibleAssetsAmortizationExpense Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) USD 2.60M 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 428,000 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 3.46M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 1.92M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 724,000 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 729,000 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 1.22M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 2.15M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap FiniteLivedIntangibleAssetsFutureAmortizationExpense Finite-Lived Intangible Assets, Future Amortization Expense (Deprecated 2012-01-31) USD 3.77M 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 29.40M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 9.90M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -1.10M 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD 2,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ForeignEarningsRepatriated Foreign Earnings Repatriated USD 2.10M 2016-04-01 2017-03-31 2016 FY 10-K 2017-05-25 0001628280-17-005885
us-gaap ForeignEarningsRepatriatedUnderAmericanJobsCreationActOf2004RepatriatedEarnings Foreign Earnings Repatriated under American Jobs Creation Act of 2004, Repatriated Earnings (Deprecated 2013-01-31) USD 1.50M 2013-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap FutureAmortizationExpenseAfterYearFive Future Amortization Expense, after Year Five (Deprecated 2012-01-31) USD 301,000 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap FutureAmortizationExpenseYearFive Future Amortization Expense, Year Five (Deprecated 2012-01-31) USD 553,000 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap FutureAmortizationExpenseYearFour Future Amortization Expense, Year Four (Deprecated 2012-01-31) USD 568,000 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap FutureAmortizationExpenseYearOne Future Amortization Expense, Year One (Deprecated 2012-01-31) USD 1.01M 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap FutureAmortizationExpenseYearThree Future Amortization Expense, Year Three (Deprecated 2012-01-31) USD 573,000 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap FutureAmortizationExpenseYearTwo Future Amortization Expense, Year Two (Deprecated 2012-01-31) USD 770,000 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 0 2017-04-01 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap GainLossOnSaleOfEquityInvestments Gain (Loss) on Sale of Equity Investments USD 1.17M 2017-04-01 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD 3.09M 2015-04-01 2016-03-31 2015 FY 10-K 2016-05-31 0001564590-16-020115
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 52.70M 2018-04-01 2019-03-31 2020 FY 10-K 2020-06-02 0001437749-20-012276
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -5.20M 2013-04-01 2014-03-31 2015 FY 10-K 2016-05-31 0001564590-16-020115
us-gaap Goodwill Goodwill USD 176.34M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 122.17M 2025-04-01 2025-12-31 2026 Q3 10-Q 2026-02-04 0001437749-26-002978
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 49.95M 2011-01-01 2011-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap GoodwillForeignCurrencyTranslationGainLoss Goodwill, Foreign Currency Translation Gain (Loss) USD 965,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap GoodwillPeriodIncreaseDecrease Goodwill, Period Increase (Decrease) USD 0 2025-04-01 2025-09-30 2026 Q2 10-Q 2025-11-05 0001437749-25-033351
us-gaap GoodwillPurchaseAccountingAdjustments Goodwill, Purchase Accounting Adjustments USD 2.67M 2025-04-01 2026-03-31 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap GoodwillTranslationAdjustments Goodwill, Translation Adjustments (Deprecated 2016-01-31) USD 2.26M 2010-04-01 2011-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap GrossProfit Gross Profit USD 51.26M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap ImpairmentOfInvestments Other than Temporary Impairment Losses, Investments USD 0 2016-04-01 2016-09-30 2016 Q2 10-Q 2016-11-02 0001628280-16-020601
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 746,000 2015-04-01 2015-09-30 2015 Q2 10-Q 2015-11-03 0001564590-15-009122
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 3.60M 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 18.64M 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 17.15M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -1.89M 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -8.55M 2015-04-01 2015-06-30 2015 Q1 10-Q 2015-08-05 0001564590-15-006142
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 96,000 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap IncomeTaxesPaid Income Taxes Paid USD 704,000 2012-04-01 2012-12-31 2013 Q3 10-Q 2014-02-06 0001564590-14-000165
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 848,000 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 4.70M 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 36,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -126.70M 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap IncomeTaxReconciliationRepatriationOfForeignEarnings Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount USD 13.20M 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -874,000 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -3.24M 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 16.39M 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -1.89M 2017-04-01 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -3.47M 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -462,000 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 10.19M 2014-04-01 2014-09-30 2014 Q2 10-Q 2014-11-06 0001564590-14-005096
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -1.96M 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap IncreaseDecreaseInPrepaidTaxes Increase (Decrease) in Prepaid Taxes USD -5.91M 2010-04-01 2011-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD -795,000 2017-04-01 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 84,000 2019-04-01 2020-03-31 2021 FY 10-K 2021-06-02 0001437749-21-013956
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 391 2018-04-01 2019-03-31 2020 FY 10-K 2020-06-02 0001437749-20-012276
us-gaap InsuranceSettlementsReceivable Insurance Settlements Receivable USD 8.20M 2013-11-19 2014 FY 10-K 2015-05-28 0001564590-15-004664
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 30.70M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 11.70M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap InterestExpense Interest Expense USD 1.00M 2015-04-01 2016-03-31 2015 FY 10-K 2016-05-31 0001564590-16-020115
us-gaap InterestExpenseDebt Interest Expense, Debt USD 200,000 2016-04-01 2016-06-30 2016 Q1 10-Q 2016-08-09 0001628280-16-018764
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD -1.03M 2014-04-01 2014-09-30 2014 Q2 10-Q 2014-11-06 0001564590-14-005096
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 2.97M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap InterestIncomeOperating Interest Income, Operating USD 830,000 2010-04-01 2011-03-31 8-K 2012-04-13 0001193125-12-162694
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 0 2018-04-01 2018-06-30 2018 Q1 10-Q 2018-07-31 0001628280-18-009847
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 42,000 2017-04-01 2018-03-31 2018 FY 10-K 2019-06-05 0001437749-19-011477
us-gaap InventoryAdjustments Inventory Adjustments USD 1.80M 2021-03-31 2021 FY 10-K 2021-06-02 0001437749-21-013956
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 1.70M 2020-12-31 2021 Q3 10-Q 2021-02-03 0001437749-21-001877
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 18.02M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap InventoryForLongTermContractsOrPrograms Inventory for Long-term Contracts or Programs, Gross USD 1.33M 2020-12-31 2021 Q3 10-Q 2021-02-03 0001437749-21-001877
us-gaap InventoryNet Inventory, Net USD 98.18M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 7.65M 2020-12-31 2021 Q3 10-Q 2021-02-03 0001437749-21-001877
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 57.81M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 3.50M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 3.50M 2020-12-31 2021 Q3 10-Q 2021-02-03 0001437749-21-001877
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 17.97M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap InventoryWriteDown Inventory Write-down USD 2.30M 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 1.51M 2017-04-01 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap LeaseCost Lease, Cost USD 1.27M 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap LegalFees Legal Fees USD 10.19M 2014-04-01 2014-12-31 2014 Q3 10-Q 2015-02-05 0001564590-15-000491
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 12.25M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 944,000 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.92M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 322,000 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 769,000 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 857,000 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.23M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.11M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 5.03M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount EUR 2.20M 2012-11-06 2012 Q2 10-Q 2012-11-06 0001193125-12-454266
us-gaap Liabilities Liabilities USD 192.53M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 774.66M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap LiabilitiesCurrent Liabilities, Current USD 148.47M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap LineOfCredit Long-term Line of Credit EUR 2.70M 2014-09-30 2014 Q2 10-Q 2014-11-06 0001564590-14-005096
us-gaap LineOfCreditFacilityAmountOutstanding Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) EUR 2.70M 2014-06-30 2014 Q1 10-Q 2014-08-05 0001564590-14-003115
us-gaap LineOfCreditFacilityDecreaseRepayments Line of Credit Facility, Decrease, Repayments (Deprecated 2013-01-31) USD 4.60M 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap LineOfCreditFacilityIncreaseAdditionalBorrowings Line of Credit Facility, Increase, Additional Borrowings (Deprecated 2013-01-31) USD 2.20M 2011-04-01 2011-09-30 2011 Q2 10-Q 2011-11-09 0000950123-11-096966
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 9.00M 2012-06-30 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap LitigationReserve Estimated Litigation Liability USD 10.32M 2014-12-31 2014 Q3 10-Q 2015-02-05 0001564590-15-000491
us-gaap LitigationSettlementAmount Litigation Settlement, Amount (Deprecated 2017-01-31) USD -8.99M 2014-04-01 2015-03-31 2014 FY 10-K 2015-05-28 0001564590-15-004664
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 0 2016-04-01 2017-03-31 2016 FY 10-K 2017-05-25 0001628280-17-005885
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 6.12M 2025-12-31 2026 Q3 10-Q 2026-02-04 0001437749-26-002978
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 0 2017-03-31 2016 FY 10-K 2017-05-25 0001628280-17-005885
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 1.80M 2013-03-31 2014 FY 10-K 2015-05-28 0001564590-15-004664
us-gaap LossContingencyDamagesAwardedValue Loss Contingency, Damages Awarded, Value USD 475,000 2011-05-18 2011-06-17 2013 Q3 10-Q 2014-02-06 0001564590-14-000165
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 10.00M 2013-11-18 2013-11-19 2014 FY 10-K 2015-05-28 0001564590-15-004664
us-gaap LossContingencyLossInPeriod Loss Contingency, Loss in Period USD 1.80M 2013-04-01 2014-03-31 2013 FY 10-K 2014-06-05 0001564590-14-002420
us-gaap LossContingencyNewClaimsFiledNumber Loss Contingency, New Claims Filed, Number Claim 7 2011-05-11 2011-05-12 2014 FY 10-K 2015-05-28 0001564590-15-004664
us-gaap LossContingencyNumberOfPlaintiffs Loss Contingency, Number of Plaintiffs plaintiff 3 2012-01-01 2012-03-31 2012 Q3 10-Q 2013-02-11 0001193125-13-048834
us-gaap LossContingencyRangeOfPossibleLossMaximum Loss Contingency, Range of Possible Loss, Maximum (Deprecated 2016-01-31) USD 2.00M 2012-12-31 2012 Q3 10-Q 2013-02-11 0001193125-13-048834
us-gaap LossContingencyRangeOfPossibleLossMinimum Loss Contingency, Range of Possible Loss, Minimum (Deprecated 2016-01-31) USD 0 2012-12-31 2012 Q3 10-Q 2013-02-11 0001193125-13-048834
us-gaap MarketableSecurities Marketable Securities USD 0 2022-09-30 2022 Q2 10-Q 2022-11-01 0001437749-22-025367
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 0 2022-03-31 2022 FY 10-K 2022-06-01 0001437749-22-014035
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 5.05M 2020-03-31 2021 FY 10-K 2021-06-02 0001437749-21-013956
us-gaap MinorityInterestIncreaseFromStockIssuance Noncontrolling Interest, Increase from Equity Issuance or Sale of Parent Equity Interest (Deprecated 2013-01-31) USD 1.06M 2009-04-01 2010-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 162,000 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 85.00M 2012-04-01 2018-06-30 2018 Q1 10-Q 2018-07-31 0001628280-18-009847
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -14.48M 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 1.28M 2017-04-01 2017-09-30 2017 Q2 10-Q 2017-11-07 0001628280-17-011077
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 48.72M 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -13.54M 2017-04-01 2017-09-30 2017 Q2 10-Q 2017-11-07 0001628280-17-011077
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 12.49M 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD -21.66M 2019-04-01 2020-03-31 2020 FY 10-K 2020-06-02 0001437749-20-012276
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -22.68M 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-02 0001437749-21-013956
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 10.00M 2010-04-01 2011-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap NontradeReceivablesCurrent Nontrade Receivables, Current USD 495,000 2012-12-31 2012 Q3 10-Q 2013-02-11 0001193125-13-048834
us-gaap NotesAndLoansReceivableGrossCurrent Financing Receivable, before Allowance for Credit Loss, Current USD 3.00M 2019-03-31 2020 FY 10-K 2020-06-02 0001437749-20-012276
us-gaap NotesAndLoansReceivableGrossNoncurrent Financing Receivable, before Allowance for Credit Loss, Noncurrent USD 3.00M 2018-03-31 2018 FY 10-K 2019-06-05 0001437749-19-011477
us-gaap NotesAndLoansReceivableNetCurrent Financing Receivable, after Allowance for Credit Loss, Current USD 2.89M 2019-03-31 2020 FY 10-K 2020-06-02 0001437749-20-012276
us-gaap NotesAndLoansReceivableNetNoncurrent Financing Receivable, after Allowance for Credit Loss, Noncurrent USD 2.66M 2018-04-01 2018 FY 10-K 2019-06-05 0001437749-19-011477
us-gaap NotesPayableCurrent Notes Payable, Current USD 0 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap NotesReceivableNet Financing Receivable, after Allowance for Credit Loss USD 3.20M 2011-12-31 2011 Q3 10-Q 2012-02-09 0001193125-12-048929
us-gaap NumberOfOperatingSegments Number of Operating Segments pure 2 2026-07-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 2 2026-07-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap NumberOfReportingUnits Number of Reporting Units pure 1 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-02 0001437749-21-013956
us-gaap OperatingExpenses Operating Expenses USD 36.06M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 15.19M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap OperatingLeaseCost Operating Lease, Cost USD 977,000 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 7.22M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.39M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 5.84M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 7.06M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 527,000 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 3.14M 2019-03-31 2018 FY 10-K 2019-06-05 0001437749-19-011477
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.12M 2019-03-31 2018 FY 10-K 2019-06-05 0001437749-19-011477
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 65,000 2019-03-31 2018 FY 10-K 2019-06-05 0001437749-19-011477
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 416,000 2019-03-31 2018 FY 10-K 2019-06-05 0001437749-19-011477
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 648,000 2019-03-31 2018 FY 10-K 2019-06-05 0001437749-19-011477
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 894,000 2019-03-31 2018 FY 10-K 2019-06-05 0001437749-19-011477
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 154,000 2015-03-31 2014 FY 10-K 2015-05-28 0001564590-15-004664
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 1.30M 2018-04-01 2019-03-31 2020 FY 10-K 2020-06-02 0001437749-20-012276
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.12 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 6.79M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 20.55M 2011-04-01 2011-12-31 2011 Q3 10-Q 2012-02-09 0001193125-12-048929
us-gaap OtherAssetsCurrent Other Assets, Current USD 53,000 2012-12-31 2012 Q3 10-Q 2013-02-11 0001193125-13-048834
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.28M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) USD 1.17M 2010-04-01 2011-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent USD -873,000 2010-04-01 2010-12-31 2010 Q3 10-Q 2011-02-03 0000950123-11-008765
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) USD -1.79M 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD 1.17M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax USD 1.17M 2010-04-01 2011-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -526,000 2026-07-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax USD 0 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-29 0001437749-24-018602
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 1.39M 2017-04-01 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) USD -1.79M 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 1.17M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2013-01-31) USD -1.17M 2010-04-01 2011-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) USD -1.17M 2010-04-01 2011-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax USD -96,000 2010-04-01 2010-12-31 2010 Q3 10-Q 2011-02-03 0000950123-11-008765
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -28,000 2012-04-01 2013-03-31 2014 FY 10-K 2015-05-28 0001564590-15-004664
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 648,000 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap OtherNoncashExpense Other Noncash Expense USD -860,000 2014-04-01 2014-09-30 2014 Q2 10-Q 2014-11-06 0001564590-14-005096
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -3,000 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -1.01M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap PaymentForContingentConsiderationLiabilityOperatingActivities Payment for Contingent Consideration Liability, Operating Activities USD 700,000 2018-01-05 2018 FY 10-K 2019-06-05 0001437749-19-011477
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 120,000 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap PaymentsForRestructuring Payments for Restructuring USD 1.00M 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-29 0001437749-24-018602
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 8.10M 2010-11-01 2010-11-30 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 0 2025-04-01 2025-12-31 2026 Q3 10-Q 2026-02-04 0001437749-26-002978
us-gaap PaymentsToAcquireAdditionalInterestInSubsidiaries Payments to Acquire Additional Interest in Subsidiaries USD 1.80M 2011-04-01 2012-03-31 2013 FY 10-K 2014-06-05 0001564590-14-002420
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 0 2022-04-01 2023-03-31 2022 FY 10-K 2023-05-31 0001437749-23-016265
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 72.10M 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 1.00M 2020-01-01 2020-03-31 2021 FY 10-K 2021-06-02 0001437749-21-013956
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 35.00M 2020-01-01 2020-03-31 2021 FY 10-K 2021-06-02 0001437749-21-013956
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 14.37M 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap PreconfirmationRestrictedCashAndCashEquivalentsCurrent Preconfirmation, Restricted Cash and Cash Equivalents, Current USD 600,000 2020-12-31 2021 Q3 10-Q 2021-02-03 0001437749-21-001877
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 12.25M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 2.81M 2012-12-31 2012 Q3 10-Q 2013-02-11 0001193125-13-048834
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 0 2016-04-01 2017-03-31 2016 FY 10-K 2017-05-25 0001628280-17-005885
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 22.28M 2015-04-01 2015-06-30 2015 Q1 10-Q 2015-08-05 0001564590-15-006142
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2021-04-01 2022-03-31 2022 FY 10-K 2022-06-01 0001437749-22-014035
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 4.68M 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 279,000 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-29 0001437749-24-018602
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 124.60M 2025-06-01 2025-06-30 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 4.63M 2011-04-01 2011-06-30 2011 Q1 10-Q 2011-09-23 0000950123-11-086250
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 0 2021-04-01 2022-03-31 2022 FY 10-K 2022-06-01 0001437749-22-014035
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 0 2022-04-01 2023-03-31 2022 FY 10-K 2023-05-31 0001437749-23-016265
us-gaap ProceedsFromSaleOfEquityMethodInvestments Proceeds from Sale of Equity Method Investments USD 127,000 2018-04-01 2019-03-31 2020 FY 10-K 2020-06-02 0001437749-20-012276
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 3.00M 2020-01-01 2020-03-31 2021 FY 10-K 2021-06-02 0001437749-21-013956
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 6.14M 2020-01-01 2020-03-31 2021 FY 10-K 2021-06-02 0001437749-21-013956
us-gaap ProductWarrantyAccrual Standard and Extended Product Warranty Accrual USD 5.43M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap ProductWarrantyAccrualAdditionsFromBusinessAcquisition Standard and Extended Product Warranty Accrual, Additions from Business Acquisition USD 450,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ProductWarrantyAccrualClassifiedCurrent Product Warranty Accrual, Current USD 5.43M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap ProductWarrantyAccrualPayments Standard and Extended Product Warranty Accrual, Decrease for Payments USD 832,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap ProductWarrantyAccrualPreexistingIncreaseDecrease Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties USD 1.58M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap ProductWarrantyAccrualWarrantiesIssued Standard and Extended Product Warranty Accrual, Increase for Warranties Issued USD 903,000 2014-04-01 2014-09-30 2014 Q2 10-Q 2014-11-06 0001564590-14-005096
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization USD 53.90M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization USD 100.87M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization USD 154.77M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 51.41M 2021-03-31 2021 FY 10-K 2021-06-02 0001437749-21-013956
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 100.87M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2019-04-01 2019-12-31 2021 Q3 10-Q 2021-02-03 0001437749-21-001877
us-gaap PurchaseCommitmentRemainingMinimumAmountCommitted Purchase Commitment, Remaining Minimum Amount Committed USD 402,000 2014-03-31 2014 FY 10-K 2015-05-28 0001564590-15-004664
us-gaap RepaymentsOfDebt Repayments of Debt USD 4.68M 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 8.81M 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 7.70M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 7.29M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 7.30M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 4.69M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap RestrictedCashAndInvestmentsCurrent Restricted Cash and Investments, Current USD 9.00M 2011-12-31 2011 Q3 10-Q 2012-02-09 0001193125-12-048929
us-gaap RestructuringAndRelatedCostExpectedCost Restructuring and Related Cost, Expected Cost (Deprecated 2014-01-31) USD 900,000 2013-04-01 2013-12-31 2013 Q3 10-Q 2014-02-06 0001564590-14-000165
us-gaap RestructuringAndRelatedCostExpectedCost1 Restructuring and Related Cost, Expected Cost USD 1.00M 2024-03-31 2024 FY 10-K 2024-05-29 0001437749-24-018602
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.05 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-29 0001437749-24-018602
us-gaap RestructuringCharges Restructuring Charges USD 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap RestructuringCosts Restructuring Costs USD 1.50M 2017-04-04 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap RestructuringCostsAndAssetImpairmentCharges Restructuring Costs and Asset Impairment Charges USD 700,000 2015-04-01 2015-09-30 2015 Q2 10-Q 2015-11-03 0001564590-15-009122
us-gaap RestructuringReserve Restructuring Reserve USD 0 2024-03-31 2024 FY 10-K 2024-05-29 0001437749-24-018602
us-gaap RestructuringReserveAccrualAdjustment Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) USD -213,000 2013-04-01 2013-12-31 2014 Q3 10-Q 2015-02-05 0001564590-15-000491
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 394,000 2017-12-31 2017 Q3 10-Q 2018-02-05 0001628280-18-000993
us-gaap RestructuringReservePeriodExpense Restructuring Reserve, Period Expense (Deprecated 2012-01-31) USD 5.65M 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap RestructuringReserveSettledWithCash Restructuring Reserve, Settled With Cash (Deprecated 2013-01-31) USD 3.71M 2012-04-01 2013-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap RestructuringReserveSettledWithoutCash1 Restructuring Reserve, Settled without Cash (Deprecated 2016-01-31) USD -215,000 2013-04-01 2014-03-31 2014 FY 10-K 2015-05-28 0001564590-15-004664
us-gaap RestructuringSettlementAndImpairmentProvisions Restructuring, Settlement and Impairment Provisions USD 779,000 2015-04-01 2016-03-31 2015 FY 10-K 2016-05-31 0001564590-16-020115
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -914.33M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 41.62M 2018-04-01 2018-12-31 2018 Q3 10-Q 2019-02-05 0001628280-19-000966
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 188.11M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 52.50M 2018-09-30 2018 Q2 10-Q 2018-11-06 0001628280-18-013770
us-gaap Revenues Revenues USD 5.30M 2019-04-01 2019-12-31 2019 Q3 10-Q 2020-02-05 0001437749-20-001789
us-gaap RevenuesFromExternalCustomers Revenue from External Customers (Deprecated 2013-01-31) USD 3.40M 2012-04-01 2013-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 3.69M 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 6 2015-04-29 2016 Q3 10-Q 2017-02-06 0001628280-17-000901
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 48.40M 2017-04-01 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap SegmentReportingOtherItemAmount SegmentReportingOtherItemAmount USD 172.92M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 36.89M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap SeveranceCosts Severance Costs (Deprecated 2013-01-31) USD 2.50M 2012-04-01 2013-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap SeveranceCosts1 Severance Costs USD 100,000 2015-04-01 2016-03-31 2016 FY 10-K 2017-05-25 0001628280-17-005885
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 11.78M 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 64.14M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value (Deprecated 2012-01-31) USD 23.46 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 926,445 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 23.79 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 1.89M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 20 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 821,707 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 2.60M 2022-04-01 2023-03-31 2022 FY 10-K 2023-05-31 0001437749-23-016265
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 10.79 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Deprecated 2012-01-31) Y 5.9 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.714 2022-04-01 2023-03-31 2024 FY 10-K 2024-05-29 0001437749-24-018602
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.042 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend USD 0 2022-04-01 2022-06-30 2022 Q1 10-Q 2022-08-03 0001437749-22-018630
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 0.74 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 66,221 2024-03-31 2024 FY 10-K 2024-05-29 0001437749-24-018602
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 712,000 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 26,503 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 6.99 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) pure 5.2 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 13.00M 2010-04-01 2011-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) USD 8.91 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 24.95 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-29 0001437749-24-018602
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 71,117 2017-04-01 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) USD 22.15 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 212,000 2013-04-01 2013-09-30 2014 Q2 10-Q 2014-11-06 0001564590-14-005096
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2,112 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) USD 9.76 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 4.06 2016-04-01 2017-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 726,000 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 28,615 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 8.49 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) pure 6.9 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 69.79 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) pure 6.8 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 725,000 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 28,560 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 8.46 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-29 0001437749-24-018602
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 119.64 2017-04-01 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-29 0001437749-24-018602
us-gaap SharePrice Share Price USD/shares 16.4 2013-12-31 2014 FY 10-K 2015-05-28 0001564590-15-004664
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 28 2025-06-30 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 88,000 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap SignificantPurchaseCommitmentRemainingMinimumAmountCommitted Purchase Commitment, Remaining Minimum Amount Committed (Deprecated 2013-01-31) USD -1.44M 2013-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap SquareFootageOfRealEstateProperty Square Footage of Real Estate Property (Deprecated 2012-01-31) pure 8,937 2011-04-01 2011-12-31 2011 Q3 10-Q 2012-02-09 0001193125-12-048929
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 582.13M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.1 2015-03-24 2016 FY 10-K 2017-05-25 0001628280-17-005885
us-gaap StockIssued1 Stock Issued USD 3.09M 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-29 0001437749-24-018602
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 9.10M 2014-11-12 2014-11-13 2014 Q3 10-Q 2015-02-05 0001564590-15-000491
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 287,000 2012-04-01 2012-09-30 2012 Q2 10-Q 2012-11-06 0001193125-12-454266
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture shares 13,174 2019-04-01 2019-06-30 2019 Q1 10-Q 2019-08-06 0001437749-19-015632
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 9,703 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 79.71M 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap StockIssuedDuringPeriodValueEmployeeBenefitPlan Stock Issued During Period, Value, Employee Benefit Plan USD 509,000 2026-07-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 161,000 2026-07-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 51.48M 2020-04-01 2021-03-31 2022 FY 10-K 2022-06-01 0001437749-22-014035
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 1.32M 2014-04-01 2015-03-31 2016 FY 10-K 2017-05-25 0001628280-17-005885
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2026-07-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 2.28M 2021-04-01 2022-03-31 2022 FY 10-K 2023-05-31 0001437749-23-016265
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 66,000 2025-07-01 2025-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap StockIssuedDuringPeriodValueTreasuryStockReissued Stock Issued During Period, Value, Treasury Stock Reissued USD 57,000 2013-04-01 2014-03-31 2013 FY 10-K 2014-06-05 0001564590-14-002420
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 600,000 2011-04-01 2011-06-30 2011 Q1 10-Q 2011-09-23 0000950123-11-086250
us-gaap SubsequentEventAmount Subsequent Event, Amount (Deprecated 2013-01-31) EUR 2.20M 2012-10-01 2012-11-06 2012 Q2 10-Q 2012-11-06 0001193125-12-454266
us-gaap SupplementalDeferredPurchasePrice Supplemental Deferred Purchase Price USD 105,000 2017-04-01 2018-03-31 2018 FY 10-K 2019-06-05 0001437749-19-011477
us-gaap TaxBenefitFromStockOptionsExercised Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) USD 52.30M 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap TaxBenefitFromStockOptionsExercised1 Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) USD 52.40M 2012-04-01 2013-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 403,351 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 3.64M 2024-03-31 2024 FY 10-K 2024-05-29 0001437749-24-018602
us-gaap TreasuryStockShares Treasury Stock, Shares shares 397,631 2022-03-31 2022 FY 10-K 2022-06-01 0001437749-22-014035
us-gaap TreasuryStockValue Treasury Stock, Value USD 3.77M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 126,000 2024-04-01 2025-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap UnbilledContractsReceivable Unbilled Contracts Receivable USD 12.01M 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap UndistributedEarnings Undistributed Earnings, Basic USD 149.00M 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap UndistributedEarningsOfForeignSubsidiaries Undistributed Earnings of Foreign Subsidiaries USD 5.50M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018542
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2017-04-01 2018-03-31 2017 FY 10-K 2018-06-06 0001628280-18-007644
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 764,000 2011-04-01 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 764,000 2011-04-01 2012-03-31 2012 FY 10-K 2013-06-14 0001193125-13-258762
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2016-03-31 2015 FY 10-K 2016-05-31 0001564590-16-020115
us-gaap USGovernmentSecuritiesAtCarryingValue US Government Securities, at Carrying Value USD 76.37M 2011-03-31 2011 Q3 10-Q 2012-02-09 0001193125-12-048929
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -5.40M 2024-04-01 2025-03-31 2025 FY 10-K 2025-05-21 0001437749-25-017986
us-gaap VariableLeaseCost Variable Lease, Cost USD 207,000 2026-01-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 600,000 2019-09-30 2020 FY 10-K 2020-06-02 0001437749-20-012276
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 47.06M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 1.93M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 48.19M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 46.26M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-04 0001437749-26-034936
us-gaap WorkersCompensationLiabilityCurrent Workers' Compensation Liability, Current USD 8.38M 2012-03-31 2011 FY 10-K 2012-06-06 0001193125-12-261967

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →